![Richard Limehouse](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Limehouse
Director/Miembro de la Junta en GeneVentiv Therapeutics, Inc. .
Cargos activos de Richard Limehouse
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GeneVentiv Therapeutics, Inc.
![]() GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race. | Director/Miembro de la Junta | - | - |
Historial de carrera de Richard Limehouse
Estadísticas
Internacional
Estados Unidos | 2 |
Operativa
Director/Board Member | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
GeneVentiv Therapeutics, Inc.
![]() GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race. | Health Technology |
- Bolsa de valores
- Insiders
- Richard Limehouse
- Experiencia